Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07389317 · ClinicalTrials.gov registry record · NA
Assessing Illustrated Medication Labels
A NA study of Health Behavior and Medication Adherence, sponsored by Wayne Sanderson.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
- 2
- Study locations
NCT07389317: Completed NA study of Health Behavior and Medication Adherence, sponsored by Wayne Sanderson.
NCT07389317 is a NA study of Health Behavior and Medication Adherence that has completed, run by Wayne Sanderson. The registered enrollment target is 87 participants, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07389317, a NA study of Health Behavior and Medication Adherence, has completed, sponsored by Wayne Sanderson.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to evaluate the impact of graphic-based medication labels on medication understanding and to assess the health literacy of our farmworker population. The main questions it aims to answer are: Primary Objective: Assess the impact of illustrated medication labels on medication understanding among migrant and seasonal farmworkers Secondary Objective: Evaluate the health literacy of the farmworker population in South Georgia Participants will be given either medication labels with pictures or standard medication labels
Primary Outcome
MUQ will assess participants' understanding of their medications after education. Scores range from 0-3 to test medication purpose, dose, and frequency
Conditions Studied
Interventions
- BEHAVIORAL standard medication label
- BEHAVIORAL Illustrated medication label
Study Locations (2)
Georgia
- Emory University - Atlanta
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2025-05-17 |
| Est. Completion | 2025-05-22 |
| Phase | NA |
What the finished NCT07389317 record still lists
NCT07389317 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which standard medication label is the first listed.
NCT07389317 reports a single indexed study location in Georgia, Kentucky.
Frequently Asked Questions
What is clinical trial NCT07389317 about?
NCT07389317 is a clinical study titled "Assessing Illustrated Medication Labels". The goal of this clinical trial is to evaluate the impact of graphic-based medication labels on medication understanding and to assess the health literacy of our farmworker population. The main questions it aims to answer are: Primary Objective: Assess the impact of illustrated medication labels on...
What is the current status of trial NCT07389317?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2025-05-17. Estimated completion is 2025-05-22.
What conditions does trial NCT07389317 study?
This clinical trial studies the following conditions: Health Behavior, Medication Adherence, Understanding of Medication Instructions.
What interventions are being tested in trial NCT07389317?
The interventions under investigation include: standard medication label (BEHAVIORAL), Illustrated medication label (BEHAVIORAL).
Who is sponsoring clinical trial NCT07389317?
This trial is sponsored by Wayne Sanderson, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07389317 being conducted?
This trial has 2 study locations across Georgia, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07389317's enrollment target sits among peer trials
87 50th of 65 higher than 16 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI